AMENDMENT NO. 1 TO THE TECHNOLOGY TRANSFER, VALIDATION AND COMMERCIAL FILL/FINISH SERVICES AGREEMENTTechnology Transfer, Validation and Commercial Fill/Finish Services Agreement • February 25th, 2021 • Revance Therapeutics, Inc. • Pharmaceutical preparations
THIS AMENDMENT NO. 1 (this “Amendment”) is made and entered into as of December 18th, 2020 (the “Amendment Effective Date”), by and between Revance Therapeutics, Inc., (“Client”), and Ajinomoto Althea, Inc., dba Aji Bio-Pharma Services (“ABPS”).
AMENDMENT TO LEASELease • February 25th, 2021 • Revance Therapeutics, Inc. • Pharmaceutical preparations
THIS AMENDMENT is made effective as of the 4th day of January, 2021, by and between 1222 DEMONBREUN, LP, a Texas limited partnership (“Landlord”), and REVANCE THERAPEUTICS, INC., a Delaware corporation (“Tenant”).
